Federal award
KBR WYLE SERVICES, LLC
2T01
Contract
Obligated and Ceiling
- Obligated (net)
- $31,223,601.77
- Ceiling (potential value, not spending)
- $37,448,209.39
- Current value
- $37,448,209.39
- Gross positive obligations
- $35,511,540.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · L693MQDFLKD1
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR WYLE SERVICES, LLC · TGPKTMN8YL31
- Awarding agency
- Department of Defense · sub-agency 5700 · office FA8075
- Funding agency
- Department of Defense · sub-agency 2100
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- 2T01
- Parent vehicle (IDV PIID)
- FA807514D0025
- Award type code
- C
- Actions
- 46 · Feb 19, 2016 to Sep 17, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History46
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 17, 2025 | FY2025 | A7 | C | −$259,507.52 | |
| Aug 12, 2025 | FY2025 | A6 | C | −$45,170.13 | |
| Jun 30, 2025 | FY2025 | A5 | C | −$1,917,358.14 | |
| May 8, 2024 | FY2024 | A4 | C | −$65,561.52 | |
| Jan 26, 2024 | FY2024 | A3 | C | −$169,213.63 | |
| Sep 28, 2023 | FY2023 | A2 | C | −$418,082.78 | |
| Sep 6, 2023 | FY2023 | A1 | C | −$49,000.00 | |
| Sep 6, 2022 | FY2022 | 37 | M | $0.00 | |
| Aug 17, 2022 | FY2022 | 36 | C | −$8,000.00 | |
| Apr 25, 2022 | FY2022 | 1A | M | −$199,089.65 | |
| Feb 17, 2022 | FY2022 | 35 | M | $0.00 | |
| Sep 29, 2021 | FY2021 | 34 | B | −$20,211.00 | |
| Sep 9, 2021 | FY2021 | 33 | C | −$93,913.06 | |
| Aug 4, 2021 | FY2021 | 32 | B | $0.00 | |
| Jul 1, 2021 | FY2021 | 31 | C | −$174,843.00 | |
| Nov 18, 2020 | FY2021 | 30 | M | $0.00 | |
| Apr 8, 2020 | FY2020 | 29 | C | $413,402.00 | |
| Mar 12, 2020 | FY2020 | 28 | B | $0.00 | |
| Feb 27, 2020 | FY2020 | 27 | B | $0.00 | |
| Dec 31, 2019 | FY2020 | 26 | C | $1,201,113.00 | |
| Dec 18, 2019 | FY2020 | 25 | C | $4,904,873.00 | |
| Nov 18, 2019 | FY2020 | 24 | G | $1,292,144.00 | |
| Mar 11, 2019 | FY2019 | 23 | C | $1,819,660.00 | |
| Feb 6, 2019 | FY2019 | 22 | C | $2,945,588.00 | |
| Dec 10, 2018 | FY2019 | 21 | G | $2,991,221.00 | |
| Nov 28, 2018 | FY2019 | 20 | B | $0.00 | |
| Sep 14, 2018 | FY2018 | 19 | B | $1,485,155.00 | |
| Mar 21, 2018 | FY2018 | 18 | C | $991,697.00 | |
| Mar 6, 2018 | FY2018 | 17 | B | $0.00 | |
| Feb 12, 2018 | FY2018 | 16 | G | $5,146,982.00 | |
| Jan 18, 2018 | FY2018 | 15 | C | $436,940.00 | |
| Oct 27, 2017 | FY2018 | 14 | M | $0.00 | |
| Sep 26, 2017 | FY2017 | 13 | M | −$867,987.80 | |
| Jul 24, 2017 | FY2017 | 12 | C | $142,700.00 | |
| Jun 12, 2017 | FY2017 | 11 | C | $1,033,650.00 | |
| Feb 28, 2017 | FY2017 | 10 | M | $1,914,745.00 | |
| Feb 15, 2017 | FY2017 | 9 | G | $2,429,510.00 | |
| Jan 11, 2017 | FY2017 | 8 | B | $0.00 | |
| Oct 27, 2016 | FY2017 | 7 | M | $0.00 | |
| Sep 28, 2016 | FY2016 | 6 | C | $206,261.00 | |
| Sep 15, 2016 | FY2016 | 5 | C | $107,948.00 | |
| Jul 7, 2016 | FY2016 | 4 | D | $645,908.00 | |
| May 5, 2016 | FY2016 | 3 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 19, 2016 | FY2016 | 2 | C | $220,321.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 31, 2016 | FY2016 | 1 | C | $933,876.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 19, 2016 | FY2016 | 0 | — | $4,247,846.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
